
H.R. 1, or the Big Beautiful Bill, has brought substantial change to the managed care pharmacy landscape, particularly for managed care organizations (MCOs) with managed Medicaid lines of business.
On Aug. 2, AMCP submitted comments in response to the 21st Century Cures 2.0 Request for Information. AMCP’s comments detail the association’s support for many of the provisions included in the Cures 2.0 Act of 2021. The bill, introduced in the previous Congress by Congresswoman Diana DeGette (D-CO), would increase coverage of innovative technologies, improve Medicaid access to high-cost therapies, and improve post-marketing studies of drugs approved through accelerated pathways.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.